Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01130103 · ClinicalTrials.gov registry record · Phase 4
Combination Treatment for Posttraumatic Stress Disorder (PTSD) After the World Trade Center (WTC) Attack
A Phase 4 study, sponsored by Research Foundation for Mental Hygiene.
- Completed
- Registry status
- Phase 4
- Development phase
- 37
- Enrollment target
NCT01130103 is a Phase 4 study that has completed, run by Research Foundation for Mental Hygiene. The registered enrollment target is 37 participants.
The verdict
NCT01130103, a Phase 4 study, has completed, sponsored by Research Foundation for Mental Hygiene.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 37 participants
- Enrollment target
Study Summary
This randomized controlled trial evaluates efficacy of combined prolonged exposure (PE) and the selective serotonin reuptake inhibitor (SSRI) paroxetine in the treatment of survivors of the World Trade Center (WTC) attacks.
Interventions
- BEHAVIORAL Prolonged Exposure Therapy
- DRUG Paroxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2004-03 |
| Est. Completion | 2010-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01130103
The ClinicalTrials.gov registry entry for NCT01130103 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Research Foundation for Mental Hygiene, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prolonged Exposure Therapy is the first listed.
NCT01130103 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01130103 about?
NCT01130103 is a clinical study titled "Combination Treatment for Posttraumatic Stress Disorder (PTSD) After the World Trade Center (WTC) Attack". This randomized controlled trial evaluates efficacy of combined prolonged exposure (PE) and the selective serotonin reuptake inhibitor (SSRI) paroxetine in the treatment of survivors of the World Trade Center (WTC) attacks.
What is the current status of trial NCT01130103?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 37 participants. The study started on 2004-03. Estimated completion is 2010-02.
What interventions are being tested in trial NCT01130103?
The interventions under investigation include: Prolonged Exposure Therapy (BEHAVIORAL), Paroxetine (DRUG).
Who is sponsoring clinical trial NCT01130103?
This trial is sponsored by Research Foundation for Mental Hygiene, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.